G Medical Innovations Holdings

General Information

(Note: “Our ordinary shares, $0.001 par value, or Ordinary Shares, currently trade on the Australian Securities Exchange operated by ASX Ltd., or ASX, under the symbol “GMV.” On May 15, 2019, the last reported trading price of our Ordinary Shares on the ASX was A$0.24, or $0.17, per share (based on the exchange rates certified for customs purposes reported by the Federal Reserve Bank of New York on such date). Our share price on the ASX may not be indicative of the actual offering price.”)

We are an early stage commercial healthcare company engaged in the development of next generation mobile and e-health solutions and monitoring service platforms. Our solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (CVD), pulmonary disease and diabetes. 

Employees: 103
Founded: 2014
Contact Information
Address 99 Baker Street, London W1U 6QQ, United Kingdom. Our telephone number in UK
Phone Number +44.20.372.92151
Web Address https://gmedinnovations.com
View Prospectus: G Medical Innovations Holdings
Financial Information
Market Cap $74.5mil
Revenues $3.0 mil (last 12 months)
Net Income $-16.98 mil (last 12 months)
IPO Profile
Symbol GMVD
Exchange NASDAQ
Shares (millions): 1.4
Price range $10.50 - $10.50
Est. $ Volume $15.0 mil
Manager / Joint Managers H.C. Wainwright & Co.
CO-Managers -
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change